Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells $217,210.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hakan Kardes sold 14,500 shares of the company’s stock in a transaction on Friday, January 24th. The stock was sold at an average price of $14.98, for a total transaction of $217,210.00. Following the completion of the transaction, the insider now directly owns 295,444 shares in the company, valued at approximately $4,425,751.12. The trade was a 4.68 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Hakan Kardes also recently made the following trade(s):

• On Tuesday, January 21st, Hakan Kardes sold 10,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $14.99, for a total transaction of $157,395.00.
• On Wednesday, November 27th, Hakan Kardes sold 35,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.80, for a total transaction of $448,000.00.
• On Monday, November 4th, Hakan Kardes sold 20,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.06, for a total transaction of $267,730.00.
• On Friday, November 1st, Hakan Kardes sold 4,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.98, for a total transaction of $58,410.00.

Alignment Healthcare Price Performance

ALHC stock opened at $14.97 on Friday. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $15.05. The company has a market cap of $2.87 billion, a P/E ratio of -19.44 and a beta of 1.45. The firm has a 50-day moving average of $12.13 and a 200 day moving average of $11.02. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.14). Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The company had revenue of $692.43 million during the quarter, compared to the consensus estimate of $662.11 million. During the same period in the prior year, the firm earned ($0.19) earnings per share. Alignment Healthcare’s revenue was up 51.6% on a year-over-year basis. On average, sell-side analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have issued reports on ALHC. KeyCorp began coverage on shares of Alignment Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating for the company. Stifel Nicolaus upped their price target on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, January 14th. UBS Group upped their price target on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research report on Wednesday, October 30th. Stephens restated an “overweight” rating and set a $17.00 price target on shares of Alignment Healthcare in a research report on Thursday, January 2nd. Finally, Barclays increased their target price on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 30th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $11.88.

Hedge Funds Weigh In On Alignment Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the business. R Squared Ltd bought a new position in shares of Alignment Healthcare during the fourth quarter valued at approximately $55,000. nVerses Capital LLC bought a new position in shares of Alignment Healthcare during the third quarter valued at approximately $95,000. Ballentine Partners LLC bought a new position in shares of Alignment Healthcare during the fourth quarter valued at approximately $121,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Alignment Healthcare during the third quarter valued at approximately $131,000. Finally, Creative Planning increased its position in shares of Alignment Healthcare by 20.0% during the third quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after acquiring an additional 2,072 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.